Safer DATA Act
Latest action · Mar 29, 2007 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMar 29, 2007
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Safer Drug Assessment Technology Advancement Act or the Safer DATA Act - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to establish: (1) minimum standards for collection and transmission of postmarketing data elements from electronic health data systems; and (2) a validated and integrated postmarket risk identification and analysis system to integrate and analyze safety data from multiple sources.
Directs the Secretary to establish and maintain an active surveillance infrastructure to collect and report data for pharmaceutical postmarket risk identification and analysis.
Requires the Secretary to establish and implement procedures under which the Secretary may routinely collaborate with a qualified entity to: (1) clean, classify, or aggregate data collected and data that is publicly available or that is provided by the Secretary; (2) perform advanced research on identified drug safety risks; (3) identify safety questions that require further clinical study; and (4) convene an expert advisory committee to oversee the establishment of standards for the ethical and scientific uses for, and communication of, postmarketing data collected.
Requires the Secretary to improve the transparency of pharmaceutical data and allow patients and health care providers better access to pharmaceutical data by developing and maintaining an Internet site that: (1) provides comprehensive drug safety information for prescription drugs; and (2) improves communication of drug safety information to patients and providers.
Cosponsors 2
Members who signed on, in the order they did. All signed on Mar 29, 2007.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-NC | Richard Burr | Original | Mar 29, 2007 |
| R-OK | Tom Coburn | Original | Mar 29, 2007 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Health, Education, Labor, and Pensions Committee | Referred Mar 29, 2007 |
Actions 2
Everything that happened, newest first.
- Mar 29, 2007Introduced in Senate
- Mar 29, 2007Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Titles 3
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to improve the underlying science of drug safety decisionmaking and strengthen the ability of the Food and Drug Administration to assess, manage, and communicate drug safety information to patients and providers.
- Short Titles as Introduced
- Safer Drug Assessment Technology Advancement Act
- Safer DATA Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Clinical trials
- Commerce
- Consumer education
- Drug approvals
- Drug interactions
- Drug utilization
- Federal advisory bodies
- Government Operations and Politics
- Health
- Health information systems
- Health surveys
- Internet
- Medical ethics
- Medical records
- Medical statistics
- Pharmaceutical research
- Product safety
- Risk
- Science, Technology, Communications
- Standards
- Web sites
Text 1
Each version as it was printed, newest first.
- Mar 29, 2007Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.